Last Updated: Dec 10 2010 - Able2Act


Fact Sheet for Pfizer Inc

Nationality: United States
Compilation by Silobreaker
Although Silobreaker has relied on what it regards as reliable sources while compiling the content herein, Silobreaker cannot guarantee the accuracy, completeness, integrity or quality of such content and no responsibility is accepted by Silobreaker in respect of such content. Readers must determine for themselves what reliance they should place on the compiled content herein.

Related Stories

First reported 1 hour ago - Updated 1 hour ago - 1 reports

Associate Quality Operations, First shift (8:00 to 4:30,

Org Marketing StatementAll over the world, Pfizer colleagues are working together to positively impact health for everyone, everywhere. Each position at Pfizer touches and contributes to the success of our business and our world. That’s why, as one of ... [Published PharmaDiversity - 1 hour ago]
First reported 8 hours ago - Updated 1 hour ago - 7 reports

Viagra Airing TV Ads Targeted At Women For The First Time

“Hey, ladies, talk about ED before you guys go on vacation.” While Viagra is a medication taken for men, they’re not the only ones who could benefit from its use. The makers of the erectile dysfunction treatment have figured out that women are a ... [Published The Consumerist - 4 hours ago]
First reported 23 hours ago - Updated 7 hours ago - 11 reports

Pfizer, Kyowa Hakko Kirin Partner to Evaluate Anticancer mAb Combo Therapy

Pfizer and Kyowa Hakko Kirin (KHK) are teaming up to explore how well the combination of Pfizer’s investigational monoclonal antibody (mAb) PF-05082566 with KHK's anti-CCR4 antibody mogamulizumab works in a Phase Ib study in patients with solid tumors. ... [Published Genetic Engineering News - 7 hours ago]
First reported 15 hours ago - Updated 9 hours ago - 2 reports

Abbott Laboratories, Pfizer Absence At PM Breakfast Meeting Gets Noticed

Two of the top 10 US pharmaceutical giants in India by their India business sales - Abbott and Pfizer - did not figure in the guest list for the breakfast meeting with Prime Minister Narendra Modi in the US on September 29.Abbott is the top pharma company ... [Published BioSpace - 9 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 3 reports

Former VP, Oncology, from Pfizer and Otsuka Joins Accelovance to Augment Oncology Growth

ROCKVILLE, Md."I'm excited to announce Dr. Purvis' addition to our company, his expertise will be invaluable as we continue our growth within early phase oncology," said Stephen TrevisanDr. Purvis brings more than 25 years of oncology drug development ... [Published Stock Nod - 12 hours ago]
First reported Sep 29 2014 - Updated 23 hours ago - 2 reports

Operations Tech Assistant – 3rd Shift 11PM – 7:30 AM

Org Marketing StatementAll over the world, Pfizer colleagues are working together to positively impact health for everyone, everywhere. Each position at Pfizer touches and contributes to the success of our business and our world. That’s why, as one of ... [Published PharmaDiversity - 23 hours ago]
First reported Sep 29 2014 - Updated 23 hours ago - 2 reports

Pfizer acquires InnoPharma

Pharmaceutical giant Pfizer Inc. has completed its acquisition of InnoPharma Inc., the company announced on Thursday.Pfizer agreed in July to make an upfront cash payment of $225 million for the pharmaceutical development company, plus up to $135 million ... [Published Processing Magazine - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 2 reports

Pfizer (PFE) Showing Neutral Technicals With Support At $29.33

For a hedged play on Pfizer Inc. (http://www.marketintelligencecenter.com/symbol/PFE"PFE) MarketIntelligenceCenter.comaEUR(TM)s algorithms selected the Jun. '15 $29.00 covered call for a net debit in the $27.94 area. That is also the break-even stock ... [Published Individual.com - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 5 reports

Research and Markets: Global Therapeutic Vaccines Market Outlook 2019 Featuring GSK, Merck, Novartis, Pfizer, Sanofi Avnetis & Serum Institute

Research and Markets ( http://www.researchandmarkets.com/research/9vl7kz/global ) has announced the addition of the "Global Therapeutic Vaccines Market- Trends And Forecasts (2014-2019)" report to their offering.Click to Continue » ... [Published Fort Mills Times - Sep 29 2014]
First reported Sep 28 2014 - Updated Sep 29 2014 - 4 reports

Pfizer's Lung Cancer Drug Xalkori Effective In Rare Gene Trial

September 29, 2014By Riley McDermid , BioSpace.com Breaking News StaffDrug giant Pfizer Inc. ( PFE ) announced Sunday that its new lung cancer drug Xalkori has proved effective in shrinking tumors in those with an even a rare genetic mutation, according ... [Published BioSpace - Sep 29 2014]
First reported Sep 29 2014 - Updated Sep 29 2014 - 2 reports

PLANDAI BIOTECHNOLOGY : Expects Pfizer Viagra Patent Ruling Will Aid in Developing All-Natural Substitute to Treat Erectile Dysfunction

- Plandaí Biotechnology ( OTCQB : PLPL ) has already begun cultivating and cloning the epimedium plants it recently acquired as part of its preliminary plans to develop and test what it anticipates will be an all-natural substitute for the widely popular ... [Published 4 Traders - Sep 29 2014]
First reported Sep 28 2014 - Updated Sep 28 2014 - 2 reports

Pfizer Shines Spotlight on Stroke Threat on World Heart Day 2014

To mark 2014 World Heart Day, which takes place on 29th September 2014, Pfizer (Thailand) Limited, one of Thailand’s largest re-based biopharmaceutical companies, has brought to light the growing threat of cardiovascular diseases (CVD). Now classified ... [Published Thailand News and Press Releases - Sep 28 2014]
In Focus
Network
Network

Blogs

sort by: Date | Relevance
Pfizer – Technical points to watch [Published Chimera Research Group - Proceed With Confidence - Apr 07 2014]
Pfizer Inc. (PFE) -NYSE A long awaited date from Pfizer revealed on Sunday April 04, 2014 at the AACR-2014. Pfizer  announced detailed results from the PALOMA-1 study, a randomized Phase 2. The post Pfizer – Technical points to watch appeared first ...
Will Pfizer Head Higher After Recent Headlines? [Published Wall St. Cheat Sheet - Feb 03 2014]
With shares of Pfizer ( NYSE:PFE ) trading around $31, is PFE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : T = Trends for a Stock’s Movement Pfizer is a biopharmaceutical ...
Is Pfizer a Good Portfolio Play? [Published Wall St. Cheat Sheet - Apr 21 2014]
With shares of Pfizer ( NYSE:PFE ) trading around $30, is PFE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : T = Trends for a Stock’s Movement Pfizer is a biopharmaceutical ...
Does Pfizer Belong in Your Portfolio? [Published Wall St. Cheat Sheet - Apr 07 2014]
With shares of Pfizer ( NYSE:PFE ) trading around $32, is PFE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : T = Trends for a Stock’s Movement Pfizer is a biopharmaceutical ...
Where Will Pfizer Go Next? [Published Wall St. Cheat Sheet - May 27 2014]
With shares of Pfizer ( NYSE:PFE ) trading around $29, is PFE an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let’s analyze the stock with the relevant sections of our CHEAT SHEET investing framework : T = Trends for a Stock’s Movement Pfizer is a biopharmaceutical ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Generics eat into Pfizer's sales [Published Reuters Video: Business - Jul 29 2014]
Pfizer's profit drops 15 pct [Published Reuters Video: Business - May 05 2014]
Pfizer to mount UK charm offensive [Published Reuters Video: Business - May 09 2014]
So why did AstraZeneca reject Pfizer? [Published Reuters Video: Business - May 19 2014]
Pfizer's bid is too bitter for Astra [Published Reuters Video: Business - May 19 2014]
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
STATEMENT REGARDING PFIZER ANNOUNCEMENT [Published GlobeNewswire: Acquisitions News - May 13 2014]
STATEMENT REGARDING PFIZER WITHDRAWAL [Published GlobeNewswire: Acquisitions News - May 27 2014]
CLARIFICATION REGARDING PFIZER STATEMENT [Published GlobeNewswire: Acquisitions News - May 20 2014]
Form 8 (OPD) Pfizer Inc. [Published GlobeNewswire: Advertising News - May 12 2014]
Fitch Affirms Pfizer's IDR at 'A+'; Outlook Stable [Published Fitch Ratings Headlines Corporate - Sep 26 2014]
1 2 3 4 5 6 7 8 9
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.